Agilent Technologies (NYSE:A) Stock Crosses Below Fifty Day Moving Average - Time to Sell?

Agilent Technologies logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Agilent shares slipped below their 50-day moving average of $171.13, trading as low as $169.40 and last changing hands at about $170.10.
  • Analyst sentiment remained positive: 18 analysts rated the stock Buy and four Hold, giving it a “Moderate Buy” consensus and an average price target of $181.45.
  • Agilent beat quarterly earnings and revenue estimates, with revenue up 8.1% year over year, and raised its quarterly dividend from $0.255 to $0.2625 per share.
  • MarketBeat previews top five stocks to own in December.

Agilent Technologies, Inc. (NYSE:A - Get Free Report) crossed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $171.13 and traded as low as $169.40. Agilent Technologies shares last traded at $170.0980, with a volume of 1,882,239 shares.

Analyst Ratings Changes

A has been the subject of several research reports. Stifel Nicolaus raised their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a "buy" rating in a research report on Thursday, August 27th. Weiss Ratings raised Agilent Technologies from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, October 8th. Citigroup upped their price target on Agilent Technologies from $185.00 to $190.00 and gave the company a "buy" rating in a research note on Thursday, August 27th. Rothschild & Co Redburn boosted their price target on shares of Agilent Technologies from $160.00 to $180.00 and gave the stock a "buy" rating in a research note on Thursday, August 27th. Finally, The Goldman Sachs Group increased their price target on Agilent Technologies from $175.00 to $185.00 and gave the company a "buy" rating in a research note on Monday, September 21st. Eighteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $181.45.

Read Our Latest Stock Analysis on Agilent Technologies

Agilent Technologies Stock Down 3.0%

The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. The stock has a market capitalization of $47.96 billion, a price-to-earnings ratio of 33.48, a P/E/G ratio of 2.54 and a beta of 1.24. The firm's fifty day simple moving average is $171.13 and its 200 day simple moving average is $139.19.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm's revenue was up 8.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 6.20 earnings per share for the current year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 27th. Shareholders of record on Tuesday, January 5th will be issued a $0.2625 dividend. The ex-dividend date of this dividend is Tuesday, January 5th. This represents a $1.05 annualized dividend and a yield of 0.6%. This is an increase from Agilent Technologies's previous quarterly dividend of $0.2550. Agilent Technologies's payout ratio is currently 20.08%.

Insiders Place Their Bets

In related news, Director Mikael Dolsten sold 634 shares of the stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the sale, the director owned 4,924 shares of the company's stock, valued at $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Bank of Nova Scotia acquired a new position in Agilent Technologies during the 2nd quarter worth approximately $58,539,000. Dudley & Shanley Inc. increased its position in shares of Agilent Technologies by 25.9% during the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company's stock worth $9,232,000 after acquiring an additional 14,300 shares in the last quarter. BIP Wealth LLC acquired a new stake in shares of Agilent Technologies in the 2nd quarter worth about $834,000. Sivia Capital Partners LLC acquired a new stake in shares of Agilent Technologies in the 2nd quarter worth about $1,818,000. Finally, KBC Group NV boosted its stake in Agilent Technologies by 18.4% during the 2nd quarter. KBC Group NV now owns 81,883 shares of the medical research company's stock valued at $10,877,000 after purchasing an additional 12,719 shares during the last quarter.

Agilent Technologies Company Profile

(Get Free Report)

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Agilent Technologies Right Now?

Before you consider Agilent Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.

While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines